TVPW
AZN icon

Third View Private Wealth’s AstraZeneca AZN Stock Holding History

Third View Private Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07M Sell
16,205
-1,859
-10% -$350K 0.38% 63
2026
Q1 		$3.56M Buy
18,064
+2,018
+13% +$389K 0.49% 49
2025
Q4 		$2.95M Buy
+16,046
New +$2.81M 0.4% 63

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Third View Private Wealth's AZN Position: Q2 2026 in Review

Third View Private Wealth reduced its AstraZeneca (AZN) stake by 10% in Q2 2026, selling an estimated $350K and leaving 16,205 shares worth $3.07M. The position accounts for 0.38% of the portfolio, ranked #63.

Third View Private Wealth first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.56M in Q1 2026. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Third View Private Wealth held 16,205 shares of AstraZeneca worth $3.07M as of Q2 2026.
  • Third View Private Wealth sold 1,859 AstraZeneca shares in Q2 2026, an estimated $350K.
  • AstraZeneca made up 0.38% of Third View Private Wealth's portfolio in Q2 2026, its #63 holding.
  • Third View Private Wealth first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Third View Private Wealth's AstraZeneca position peaked at $3.56M in Q1 2026.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Third View Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.